AnaptysBio - WI(ANABV.US)

Company Encyclopedia

AnaptysBio - WI

ANABV.US

1.939 T

ANABV.USMarket value -Rank by Market Cap -/-

Financial Score

15/04/2026 Update

BiotechnologyIndustry

Industry Ranking118/393

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreD
- ROE-24.49%E
- Profit Margin-5.64%D
- Gross Margin42.04%B
Growth ScoreB
- Revenue YoY157.01%A
- Net Profit YoY90.89%A
- Total Assets YoY-24.69%E
- Net Assets YoY-47.49%E
Cash ScoreC
- Cash Flow Margin-148.86%E
- OCF YoY157.01%A
Operating ScoreC
- Turnover0.55C
Debt ScoreE
- Gearing Ratio89.79%E

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
EcoR1 Capital, LLC	27.41%	No Change	31/12/2025
Point72 Asset Management, L.P.	6.72%	-332.64 K	31/12/2025
BlackRock, Inc.	6.03%	12.11 K	31/12/2025
The Vanguard Group, Inc.	5.37%	67.05 K	31/12/2025
Tang Capital Management, LLC	4.63%	-1.55 K	31/12/2025
State Street Global Advisors, Inc.	3.66%	180.04 K	31/12/2025
Morgan Stanley	3.5%	-521.89 K	31/12/2025
Sanofi	2.86%	No Change	31/12/2025
Millennium Management LLC	2.83%	No Change	15/01/2026
Palo Alto Investors LP	2.4%	16.51 K	31/12/2025

AnaptysBio - WI(ANABV.US)

AnaptysBio - WI Stock Performance Chart

Financial Score

Valuation analysis

Institutional View & Shareholder

Analyst Ratings